Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fu Ke Tiao Jing Ke Li
- Development stage
- Unknown
- Lead developer
- Sinopharm Group Zhijun
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Fu Ke Tiao Jing Ke Li (also known as Fuke Tiaojing Keli) is an approved traditional Chinese medicine (TCM) formulation developed and manufactured by Sinopharm Group Zhijun. It is formulated as oral granules and is indicated for the treatment of irregular menstruation and dysmenorrhea (menstrual abdominal pain). The formulation is a multi-herb mixture containing several traditional Chinese medicinal herbs, including Radix Angelicae Sinensis (Dang Gui), Rhizoma Chuanxiong (Chuan Xiong), Rhizoma Cyperi (Xiang Fu), Rhizoma Atractylodis Macrocephalae (Bai Zhu), Radix Paeoniae Alba (Bai Shao), Radix Paeoniae Rubra (Chi Shao), Rhizoma Corydalis (Yan Hu Suo), Radix Rehmanniae Praeparata (Shu Di Huang), Fructus Jujubae (Da Zao), and Radix et Rhizoma Glycyrrhizae (Gan Cao). It functions primarily by nourishing blood, regulating menstruation, and relieving pain.
- Brand names
- De Yi Pin
- Other names
- Fuke Tiaojing GranuleFuke Tiaojing Keli妇科调经颗粒
Beyond the preview
Go deeper on Fu Ke Tiao Jing Ke Li.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Fu Ke Tiao Jing Ke Li.